Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 1783 results found since Jan 2013.
Herpetic anterior uveitis following Pfizer-BioNTech coronavirus disease 2019 vaccine: two case reports
CONCLUSION: Clinicians should be aware of the possibility of eye inflammation in the form of herpetic reactivation after coronavirus disease 2019 vaccination.PMID:35337364 | PMC:PMC8949824 | DOI:10.1186/s13256-022-03350-6
Source: Herpes - March 26, 2022 Category: Infectious Diseases Authors: Jos é Manuel Ortiz-Egea Cristina G ómez Sánchez Andr és López-Jiménez Olga Diego Navarro Source Type: research
Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles
Viruses. 2022 Mar 12;14(3):588. doi: 10.3390/v14030588.ABSTRACTVaricella-zoster virus (VZV) causes varicella as a primary infection and remains latent in the ganglia until it becomes reactivated to cause herpes zoster. Individuals with varicella develop adaptive humoral and cell-mediated immunity. Compromised cell-mediated immunity is thought to contribute to the development of herpes zoster. Recent evidence suggests that changes in the epidemiology of varicella have affected the epidemiology of herpes zoster. The incidence of herpes zoster is higher in older adults; thus, the herpes zoster vaccine is recommended for older...
Source: Herpes - March 26, 2022 Category: Infectious Diseases Authors: Naruhito Otani Masayuki Shima Takuma Yamamoto Toshiomi Okuno Source Type: research
Knowledge and Attitudes Concerning Herpes Zoster among People with COPD: An Interventional Survey Study
Vaccines (Basel). 2022 Mar 10;10(3):420. doi: 10.3390/vaccines10030420.ABSTRACTHerpes zoster (HZ) is common in older adults with conditions such as chronic obstructive pulmonary disease (COPD). Effective prevention is available through vaccination, but HZ vaccine uptake remains incomplete. Using an online survey of people with self-reported COPD, ShiPPS assessed HZ risk awareness, HZ vaccine use and barriers, and the impact of an HZ educational video on vaccine intent. USA members of the COPD Foundation's Patient-Powered Research Network aged >50 years were surveyed in fall 2020. The responses were analyzed using de...
Source: Herpes - March 26, 2022 Category: Infectious Diseases Authors: Barbara P Yawn Debora D Merrill Sergio Martinez Elisabeth Callen Janice Cotton Dennis Williams Natalia Y Loskutova Source Type: research
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review
Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022.ABSTRACTHerpes zoster (HZ) is a neurocutaneous disease that causes significant morbidity worldwide. The disease is caused by the reactivation of the varicella-zoster virus (VZV), which leads to the development of a painful, vesicular rash and can cause complications such as post-herpetic neuralgia and vision loss. Globally, the incidence of HZ is increasing, and it incurs billions in cost annually to the healthcare system and to society through loss of productivity. With the advent of effective vaccines such as ...
Source: Herpes - March 28, 2022 Category: Infectious Diseases Authors: Catherina X Pan Michelle S Lee Vinod E Nambudiri Source Type: research
Increased Risk of Herpes Zoster in Adults 50 Years Old Diagnosed With COVID-19 in the United States
CONCLUSIONS: We found that COVID-19 diagnosis in ≥50-year-olds was associated with a significantly increased risk of developing HZ, highlighting the relevance of maintaining HZ vaccination.PMID:35392454 | PMC:PMC8982770 | DOI:10.1093/ofid/ofac118
Source: Herpes - April 8, 2022 Category: Infectious Diseases Authors: Amit Bhavsar Germain Lonnet Chengbin Wang Konstantina Chatzikonstantinidou Raunak Parikh Yves Brabant Nathalie Servotte Meng Shi Robyn Widenmaier Emmanuel Aris Source Type: research
Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020
DISCUSSION: Our study shows a clear association of shingles vaccination with reduced dementia, consistent with other observational cohort studies. The association may reflect selection bias with people choosing to be vaccinated having a higher healthy life expectancy.PMID:35434253 | PMC:PMC9006884 | DOI:10.1002/trc2.12293
Source: Herpes - April 18, 2022 Category: Infectious Diseases Authors: Christian Schnier Janet Janbek Richard Lathe J ürgen Haas Source Type: research
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine. The development of herpes zoster ophthalmicus following HZ/su is exceedingly rare, with only one prior reported case found in the literature. Reporting of this potential correlation is important in understanding the full risks of vaccines and can help elucidate the etiology of such responses.PMID:35431886 | PMC:PMC8958576 | DOI:10.1159/000522272
Source: Herpes - April 18, 2022 Category: Infectious Diseases Authors: Tracy J Lu Christopher N Ta Source Type: research
Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020
DISCUSSION: Our study shows a clear association of shingles vaccination with reduced dementia, consistent with other observational cohort studies. The association may reflect selection bias with people choosing to be vaccinated having a higher healthy life expectancy.PMID:35434253 | PMC:PMC9006884 | DOI:10.1002/trc2.12293
Source: Herpes - April 18, 2022 Category: Infectious Diseases Authors: Christian Schnier Janet Janbek Richard Lathe J ürgen Haas Source Type: research
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine. The development of herpes zoster ophthalmicus following HZ/su is exceedingly rare, with only one prior reported case found in the literature. Reporting of this potential correlation is important in understanding the full risks of vaccines and can help elucidate the etiology of such responses.PMID:35431886 | PMC:PMC8958576 | DOI:10.1159/000522272
Source: Herpes - April 18, 2022 Category: Infectious Diseases Authors: Tracy J Lu Christopher N Ta Source Type: research
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Vaccines (Basel). 2022 Apr 13;10(4):607. doi: 10.3390/vaccines10040607.ABSTRACTOrganismal ageing is associated with many physiological changes, including differences in the immune system of most animals. These differences are often considered to be a key cause of age-associated diseases as well as decreased vaccine responses in humans. The most often cited vaccine failure is seasonal influenza, but, while it is usually the case that the efficiency of this vaccine is lower in older than younger adults, this is not always true, and the reasons for the differential responses are manifold. Undoubtedly, changes in the innate an...
Source: Herpes - April 23, 2022 Category: Infectious Diseases Authors: Tamas Fulop Anis Larbi Graham Pawelec Alan A Cohen Guillaume Provost Abedelouahed Khalil Guy Lacombe Serafim Rodrigues Mathieu Desroches Katsuiku Hirokawa Claudio Franceschi Jacek M Witkowski Source Type: research
Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study
In conclusion, the coverage of recommended vaccinations is low. Higher SELFY-MPI scores and vaccination status, particularly anti-pneumococcus, appear to be associated, but future studies are urgently needed for confirming that frailty is associated with vaccination status in older people.PMID:35455304 | PMC:PMC9028390 | DOI:10.3390/vaccines10040555
Source: Herpes - April 23, 2022 Category: Infectious Diseases Authors: Nicola Veronese Giusy Vassallo Maria Armata Laura Cilona Salvatore Casalicchio Roberta Masnata Claudio Costantino Francesco Vitale Giovanni Maurizio Giammanco Stefania Maggi Shaun Sabico Nasser M Al-Daghri Ligia J Dominguez Mario Barbagallo Source Type: research
Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
Vaccines (Basel). 2022 Mar 29;10(4):529. doi: 10.3390/vaccines10040529.ABSTRACTHerpes zoster (HZ) is one of two distinct syndromes caused by Varicella-zoster virus (VZV). A primary infection with VZV causes varicella in susceptible young children. After resolution of the primary infection, VZV establishes a lifelong latency within the cranial or dorsal root ganglia. With increasing age, family history of shingles, immunosuppression or other risk factors, there is a decline in the virus-specific T-cell-mediated immune (CMI) response which allows reactivation of latent VZV in the root ganglia resulting in HZ. There are curre...
Source: Herpes - April 23, 2022 Category: Infectious Diseases Authors: Junli Li Lili Fu Yang Yang Guozhi Wang Aihua Zhao Source Type: research
Apparent lack of association of COVID-19 vaccination with Herpes Zoster
CONCLUSIONS AND IMPORTANCE: This study did not find evidence of an association between COVID-19 vaccination and a new diagnosis of HZ. We encourage health care professionals to strongly recommend COVID-19 vaccinations per Centers for Disease Control (CDC) recommendations and vaccination against HZ according to Food and Drug Administration (FDA) approval for the recombinant zoster vaccine.PMID:35474754 | PMC:PMC9021123 | DOI:10.1016/j.ajoc.2022.101549
Source: Herpes - April 27, 2022 Category: Infectious Diseases Authors: Sachi A Patil Levi Dygert Steven L Galetta Laura J Balcer Elisabeth J Cohen Source Type: research
Strategies to improve vaccination rates in people who are homeless: A systematic review
Vaccine. 2022 Apr 25:S0264-410X(22)00436-4. doi: 10.1016/j.vaccine.2022.04.022. Online ahead of print.ABSTRACTPeople who are homeless experience higher rates of vaccine-preventable disease, including COVID-19, than the general population, and poorer associated health outcomes. However, delivering vaccinations to people who are homeless is complex, and there is a lack of evidence to inform practice in this area. The aim of this systematic review is to: (a) identify, (b) analyse the characteristics of, and (c) evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless. Literature was retriev...
Source: Vaccine - April 28, 2022 Category: Allergy & Immunology Authors: Laura K McCosker Asmaa El-Heneidy Holly Seale Robert S Ware Martin J Downes Source Type: research
